Control of HIV despite the Discontinuation of Antiretroviral Therapy

Julianna Lisziewicz(National Institutes of Health), Franco Lori(Research Institute for Genetic and Human Therapy), Bruce D. Walker(Howard Hughes Medical Institute), Heiko Jessen(Praxis (United States)), Robert F. Siliciano(Howard Hughes Medical Institute), Lucia Lopalco(Vita-Salute San Raffaele University), Eric Rosenberg(Harvard University), Judy Lieberman(Boston Children's Hospital)
New England Journal of Medicine
May 27, 1999
10.1056/nejm199905273402114
Cited by 328

Related Papers

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
|Immunity|2015|824